286 related articles for article (PubMed ID: 28923793)
1. Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).
Florea V; Rieger AC; DiFede DL; El-Khorazaty J; Natsumeda M; Banerjee MN; Tompkins BA; Khan A; Schulman IH; Landin AM; Mushtaq M; Golpanian S; Lowery MH; Byrnes JJ; Hendel RC; Cohen MG; Valasaki K; Pujol MV; Ghersin E; Miki R; Delgado C; Abuzeid F; Vidro-Casiano M; Saltzman RG; DaFonseca D; Caceres LV; Ramdas KN; Mendizabal A; Heldman AW; Mitrani RD; Hare JM
Circ Res; 2017 Nov; 121(11):1279-1290. PubMed ID: 28923793
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
[TBL] [Abstract][Full Text] [Related]
3. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
Hare JM; Fishman JE; Gerstenblith G; DiFede Velazquez DL; Zambrano JP; Suncion VY; Tracy M; Ghersin E; Johnston PV; Brinker JA; Breton E; Davis-Sproul J; Schulman IH; Byrnes J; Mendizabal AM; Lowery MH; Rouy D; Altman P; Wong Po Foo C; Ruiz P; Amador A; Da Silva J; McNiece IK; Heldman AW; George R; Lardo A
JAMA; 2012 Dec; 308(22):2369-79. PubMed ID: 23117550
[TBL] [Abstract][Full Text] [Related]
4. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
Heldman AW; DiFede DL; Fishman JE; Zambrano JP; Trachtenberg BH; Karantalis V; Mushtaq M; Williams AR; Suncion VY; McNiece IK; Ghersin E; Soto V; Lopera G; Miki R; Willens H; Hendel R; Mitrani R; Pattany P; Feigenbaum G; Oskouei B; Byrnes J; Lowery MH; Sierra J; Pujol MV; Delgado C; Gonzalez PJ; Rodriguez JE; Bagno LL; Rouy D; Altman P; Foo CW; da Silva J; Anderson E; Schwarz R; Mendizabal A; Hare JM
JAMA; 2014 Jan; 311(1):62-73. PubMed ID: 24247587
[TBL] [Abstract][Full Text] [Related]
5. Effects of transendocardial CD34+ cell transplantation in patients with ischemic cardiomyopathy.
Poglajen G; Sever M; Cukjati M; Cernelc P; Knezevic I; Zemljic G; Haddad F; Wu JC; Vrtovec B
Circ Cardiovasc Interv; 2014 Aug; 7(4):552-9. PubMed ID: 25097199
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Transendocardial Stem Cell Injection on Erectile Function in Men With Cardiomyopathy: Results From the TRIDENT, POSEIDON, and TAC-HFT Trials.
Ory J; Saltzman RG; Blachman-Braun R; Dadoun S; DiFede DL; Premer C; Hurwitz B; Hare JM; Ramasamy R
J Sex Med; 2020 Apr; 17(4):695-701. PubMed ID: 32059936
[TBL] [Abstract][Full Text] [Related]
7. Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial.
Anastasiadis K; Antonitsis P; Westaby S; Reginald A; Sultan S; Doumas A; Efthimiadis G; Evans MJ
J Cardiovasc Transl Res; 2016 Jun; 9(3):202-213. PubMed ID: 27037806
[TBL] [Abstract][Full Text] [Related]
8. Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial.
Butler J; Epstein SE; Greene SJ; Quyyumi AA; Sikora S; Kim RJ; Anderson AS; Wilcox JE; Tankovich NI; Lipinski MJ; Ko YA; Margulies KB; Cole RT; Skopicki HA; Gheorghiade M
Circ Res; 2017 Jan; 120(2):332-340. PubMed ID: 27856497
[TBL] [Abstract][Full Text] [Related]
9. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling.
Williams AR; Trachtenberg B; Velazquez DL; McNiece I; Altman P; Rouy D; Mendizabal AM; Pattany PM; Lopera GA; Fishman J; Zambrano JP; Heldman AW; Hare JM
Circ Res; 2011 Apr; 108(7):792-6. PubMed ID: 21415390
[TBL] [Abstract][Full Text] [Related]
10. Cell Spray Transplantation of Adipose-derived Mesenchymal Stem Cell Recovers Ischemic Cardiomyopathy in a Porcine Model.
Mori D; Miyagawa S; Yajima S; Saito S; Fukushima S; Ueno T; Toda K; Kawai K; Kurata H; Nishida H; Isohashi K; Hatazawa J; Sawa Y
Transplantation; 2018 Dec; 102(12):2012-2024. PubMed ID: 30048399
[TBL] [Abstract][Full Text] [Related]
11. COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design.
Mansour S; Roy DC; Bouchard V; Nguyen BK; Stevens LM; Gobeil F; Rivard A; Leclerc G; Reeves F; Noiseux N
J Cardiovasc Transl Res; 2010 Apr; 3(2):153-9. PubMed ID: 20560029
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM
J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249
[TBL] [Abstract][Full Text] [Related]
13. Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure.
Qayyum AA; Mouridsen M; Nilsson B; Gustafsson I; Schou M; Nielsen OW; Hove JD; Mathiasen AB; Jørgensen E; Helqvist S; Joshi FR; Johansen EM; Follin B; Juhl M; Højgaard LD; Haack-Sørensen M; Ekblond A; Kastrup J
ESC Heart Fail; 2023 Apr; 10(2):1170-1183. PubMed ID: 36638837
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
15. Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
Hare JM; DiFede DL; Rieger AC; Florea V; Landin AM; El-Khorazaty J; Khan A; Mushtaq M; Lowery MH; Byrnes JJ; Hendel RC; Cohen MG; Alfonso CE; Valasaki K; Pujol MV; Golpanian S; Ghersin E; Fishman JE; Pattany P; Gomes SA; Delgado C; Miki R; Abuzeid F; Vidro-Casiano M; Premer C; Medina A; Porras V; Hatzistergos KE; Anderson E; Mendizabal A; Mitrani R; Heldman AW
J Am Coll Cardiol; 2017 Feb; 69(5):526-537. PubMed ID: 27856208
[TBL] [Abstract][Full Text] [Related]
16. Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study.
Penn MS; Ellis S; Gandhi S; Greenbaum A; Hodes Z; Mendelsohn FO; Strasser D; Ting AE; Sherman W
Circ Res; 2012 Jan; 110(2):304-11. PubMed ID: 22052917
[TBL] [Abstract][Full Text] [Related]
17. Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy.
Park K; Lai D; Handberg EM; Moyé L; Perin EC; Pepine CJ; Anderson RD
Tex Heart Inst J; 2016 Aug; 43(4):291-6. PubMed ID: 27547135
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
[TBL] [Abstract][Full Text] [Related]
19. Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial.
Suncion VY; Ghersin E; Fishman JE; Zambrano JP; Karantalis V; Mandel N; Nelson KH; Gerstenblith G; DiFede Velazquez DL; Breton E; Sitammagari K; Schulman IH; Taldone SN; Williams AR; Sanina C; Johnston PV; Brinker J; Altman P; Mushtaq M; Trachtenberg B; Mendizabal AM; Tracy M; Da Silva J; McNiece IK; Lardo AC; George RT; Hare JM; Heldman AW
Circ Res; 2014 Apr; 114(8):1292-301. PubMed ID: 24449819
[TBL] [Abstract][Full Text] [Related]
20. Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.
Luger D; Lipinski MJ; Westman PC; Glover DK; Dimastromatteo J; Frias JC; Albelda MT; Sikora S; Kharazi A; Vertelov G; Waksman R; Epstein SE
Circ Res; 2017 May; 120(10):1598-1613. PubMed ID: 28232595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
